SCHEMBL6325121

SCHEMBL6325121

Cc1ccc(-c2noc(CCCC(=O)NCCNc3n[nH]c(=O)c4ccccc34)n2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.54
TSHR P16473 6/20 0.54
SMN1; SMN2 Q16637 4/20 0.54
HDAC1 Q13547 2/20 0.52
HDAC2 Q92769 2/20 0.52
HDAC8 Q9BY41 2/20 0.52
MAPT P10636 2/20 0.51
LMNA P02545 7/20 0.50
HTT P42858 4/20 0.50
USP2 O75604 3/20 0.50
MAPK1 P28482 3/20 0.50
HPGD P15428 4/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
ALDH1A1 P00352 4/20 0.47
ALOX15 P16050 1/20 0.47
TP53 P04637 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6332642 0.96 GAA (0.54) GAATSHRSMN1; SMN2HDAC1HDAC2
SCHEMBL6328500 0.96 GAA (0.54) GAATSHRSMN1; SMN2HDAC1HDAC2
SCHEMBL6326417 0.95 TSHR (0.60) TSHRSMN1; SMN2MAPTLMNAHTT
SCHEMBL6325765 0.93 ALDH1A1 (0.54) GAATSHRSMN1; SMN2HDAC1HDAC2
SCHEMBL6324086 0.92 HDAC1 (0.52) TSHRSMN1; SMN2HDAC1HDAC2MAPT
SCHEMBL6325574 0.92 TSHR (0.58) GAATSHRSMN1; SMN2MAPTLMNA
SCHEMBL6327228 0.92 TSHR (0.58) GAATSHRSMN1; SMN2MAPTLMNA
SCHEMBL6330578 0.91 LMNA (0.51) GAATSHRSMN1; SMN2HDAC1HDAC2
SCHEMBL6332801 0.89 HPGD (0.53) GAATSHRSMN1; SMN2HDAC1HDAC2
SCHEMBL6328158 0.89 HPGD (0.53) GAATSHRSMN1; SMN2HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6924284-B2 PARP inhibitors ICOS CORPORATION (US) 2005-08-02 US disclosed